Patient Square Eyes $4B Goal for What Could Be Largest-Ever First-Time Fund

The non-cash goodwill impairment charge of $13.4 billion reported over the past year reflects the waning market value of Teladoc’s $18.5 billion acquisition of chronic care company Livongo in late 2020.

Current trends indicate a market correction is underway, but some VC investors say they are excited about this market “reset,” as it represents an opportunity for mission-driven founders to thrive.

Compressed valuations, heightened boardroom CEO confidence across various sub-sectors, and the need to accelerate top-line growth and scale are all indicative of a wave of deal activity.